GlaxoSmithKline plc Stock
€20.97
Your prediction
GlaxoSmithKline plc Stock
Pros and Cons of GlaxoSmithKline plc in the next few years
Pros
Cons
Performance of GlaxoSmithKline plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
GlaxoSmithKline plc | 2.900% | -0.318% | -4.140% | 25.927% | 3.954% | 15.178% | 4.874% |
AstraZeneca plc | 2.390% | 2.488% | -3.762% | 31.636% | 17.255% | 79.362% | 101.493% |
Merck KGaA | 2.620% | 4.448% | -6.877% | 17.290% | -26.392% | 83.257% | 55.808% |
Eli Lilly Corp. | 3.760% | -3.946% | -1.853% | 67.358% | 9.570% | 159.808% | 289.393% |
Comments
News
New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+
According to a new study conducted by GSK, people age 50 or older in the US who have had COVID-19 may be at greater risk of developing shingles – a painful rash – compared to those who haven’t been

Alacer Corp. Launches New Eco-Conscious Toothpaste Brand Natean®
Alacer Corp. today announced the launch of Natean®, a new eco-conscious oral healthcare brand providing products to consumers looking for nature-inspired toothpastes that deliver essential oral
Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows
Centers for Disease Control and Prevention (CDC)-recommended vaccinations for teens and adults continued to lag in 2020 and into the summer of 2021, according to a follow-up claims analysis